These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 949550)

  • 21. Denaturation of the normal and abnormal hemoglobin molecule.
    Rachmilewitz EA
    Semin Hematol; 1974 Oct; 11(4):441-62. PubMed ID: 4371697
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of erythrocyte sickling in vitro by pyridoxal.
    Kark JA; Kale MP; Tarassoff PG; Woods M; Lessin LS
    J Clin Invest; 1978 Oct; 62(4):888-91. PubMed ID: 701485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygous state for Hb Constant Spring (slow-moving Hb X components).
    Lie-Injo LE; Ganesan J; Clegg JB; Weatherall DJ
    Blood; 1974 Feb; 43(2):251-9. PubMed ID: 4810076
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
    Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
    Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of HIV-1 infection by alkylureas.
    Goldstein H; Pettoello-Mantovani M; Kollmann TR; Calvelli TA; Rubinstein A
    AIDS; 1991 Dec; 5(12):1447-52. PubMed ID: 1726039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 effects on oxygen affinity by sickle erythrocytes.
    Rabinowitz I; Wolf PL; Shikuma N; Berman S
    Prostaglandins; 1974 Aug; 7(4):309-17. PubMed ID: 4415346
    [No Abstract]   [Full Text] [Related]  

  • 28. Sickle cells modified by an osmotic pulse in the presence of inositol hexaphosphate have decreased intracellular hemoglobin concentration and decreased in vitro sickling without prolonged in vivo survival.
    Franco R; Barker-Gear R; Silberstein E; Mayfield G; Weiner M; Palascak J; Green R
    Adv Exp Med Biol; 1992; 326():325-31. PubMed ID: 1295319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle cell hemoglobin: molecular basis of sickling phenomenon theory and therapy.
    Murayama M
    CRC Crit Rev Biochem; 1973 Sep; 1(4):461-99. PubMed ID: 4594860
    [No Abstract]   [Full Text] [Related]  

  • 30. The molecular basis of antisickling agents.
    Franklin IM; Huehns ER
    Trans R Soc Trop Med Hyg; 1980; 74(6):695-700. PubMed ID: 7210123
    [No Abstract]   [Full Text] [Related]  

  • 31. Sickling reversed and blocked by urea in invert sugar.
    Nalbandian RM; Henry RL; Barnhart MI; Nichols BM; Camp FR; Wolf PL
    Am J Pathol; 1971 Aug; 64(2):405-22. PubMed ID: 5142273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte glutathione peroxidase deficiency. Biochemical studies on the mechanisms of drug-induced hemolysis.
    Steinberg MH; Necheles TF
    Am J Med; 1971 Apr; 50(4):542-6. PubMed ID: 5572598
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of glyceraldehyde on the structural and functional properties of sickle erythrocytes.
    Nigen AM; Manning JM
    J Clin Invest; 1978 Jan; 61(1):11-9. PubMed ID: 618907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing haemoglobin oxygen affinity to prevent sickling: abnormal haemoglobin variants as models.
    Franklin IM; Huehns ER; Rosemeyer MA
    Br J Haematol; 1986 Oct; 64(2):319-29. PubMed ID: 3778826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Delay time of gelation: a possible determinant of clinical severity in sickle cell disease.
    Eaton WA; Hofrichter J; Ross PD
    Blood; 1976 Apr; 47(4):621-7. PubMed ID: 1260125
    [No Abstract]   [Full Text] [Related]  

  • 36. Methemoglobin formation and reduction in relation to hemoglobin oxygen affinity.
    Mansouri A
    Experientia; 1981 Jan; 37(1):95-6. PubMed ID: 7202682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SC erythrocytes have an abnormally high intracellular hemoglobin concentration. Pathophysiological consequences.
    Fabry ME; Kaul DK; Raventos-Suarez C; Chang H; Nagel RL
    J Clin Invest; 1982 Dec; 70(6):1315-9. PubMed ID: 7174796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The enzymes of erythrocytes and their functional importance].
    Löhr GW
    Folia Haematol (Frankf); 1964; 9(3):240-58. PubMed ID: 5888804
    [No Abstract]   [Full Text] [Related]  

  • 39. Urea, urease, cyanate, and the sickling of hemoglobin S.
    Nalbandian RM; Nichols BM; Stehouwer EJ; Camp FR
    Clin Chem; 1972 Sep; 18(9):961-4. PubMed ID: 5052097
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemoglobin Köln disease occurring as a fresh mutation: erythrocyte metabolism and survival.
    Miller DR; Weed RI; Stamatoyannopoulos G; Yoshida A
    Blood; 1971 Dec; 38(6):715-29. PubMed ID: 4942314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.